1,493 results on '"Ratjen, Felix"'
Search Results
2. Reply to Eker et al. Comment on Kilian et al. Comparing Characteristics and Treatment of Brain Vascular Malformations in Children and Adults with HHT. J. Clin. Med. 2023, 12, 2704.
3. Early human fetal lung atlas reveals the temporal dynamics of epithelial cell plasticity
4. Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials.
5. Comparing Characteristics and Treatment of Brain Vascular Malformations in Children and Adults with HHT
6. De Novo Brain Vascular Malformations in Hereditary Hemorrhagic Telangiectasia
7. Standards for the care of people with cystic fibrosis (CF); recognising and addressing CF health issues
8. Semiautomated Segmentation and Analysis of Airway Lumen in Pediatric Patients Using Ultra Short Echo Time MRI
9. Assessing 129Xe multi-breath washout MRI response to elexacaftor/tezacaftor/ivacaftor intervention in pediatric CF
10. Longitudinal Assessment of Curaçao Criteria in Children with Hereditary Hemorrhagic Telangiectasia
11. Clinical and functional efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis carrying the N1303K mutation
12. Advancing the pipeline of cystic fibrosis clinical trials: a new roadmap with a global trial network perspective
13. Automatic bronchus and artery analysis on chest computed tomography to evaluate the effect of inhaled hypertonic saline in children aged 3-6 years with cystic fibrosis in a randomized clinical trial
14. Cost-effectiveness analysis of genetic tools to predict treatment response in patients with cystic fibrosis
15. Exhaled breath profiles to detect lung infection with Staphylococcus aureus in children with cystic fibrosis
16. Effects of elexacaftor/tezacaftor/ivacaftor therapy in children with cystic fibrosis – a comprehensive assessment using lung clearance index, spirometry, and functional and structural lung MRI
17. Genotype-Phenotype Correlations in Children with HHT.
18. Estimating the minimum sample size for interventional and observational studies using the lung clearance index as an endpoint✰
19. Elexacaftor/tezacaftor/ivacaftor and gastrointestinal outcomes in cystic fibrosis: Report of promise-GI
20. Comparative analysis of respiratory symptom scores to detect acute respiratory events in children with cystic fibrosis
21. High-quality read-based phasing of cystic fibrosis cohort informs genetic understanding of disease modification
22. Impact of antibiotic eradication therapy of Pseudomonas aeruginosa on long term lung function in cystic fibrosis
23. The effect of antibiotic changes during treatment of cystic fibrosis pulmonary exacerbations
24. The effect of inhaled hypertonic saline on lung structure in children aged 3–6 years with cystic fibrosis (SHIP-CT): a multicentre, randomised, double-blind, controlled trial
25. Genetic evidence supports the development of SLC26A9 targeting therapies for the treatment of lung disease
26. Exercise intolerance in cystic fibrosis-the role of CFTR modulator therapies
27. Effects of Traffic-Related Air Pollution on Exercise Endurance, Dyspnea, and Cardiorespiratory Responses in Health and COPD: A Randomized, Placebo-Controlled, Crossover Trial
28. Cystic Fibrosis: Treatment
29. Riociguat for the treatment of Phe508del homozygous adults with cystic fibrosis
30. Long-term safety of lumacaftor–ivacaftor in children aged 2–5 years with cystic fibrosis homozygous for the F508del-CFTR mutation: a multicentre, phase 3, open-label, extension study
31. Comparison of Functional Free-Breathing Pulmonary 1H and Hyperpolarized 129Xe Magnetic Resonance Imaging in Pediatric Cystic Fibrosis
32. Long-term safety and efficacy of lumacaftor–ivacaftor therapy in children aged 6–11 years with cystic fibrosis homozygous for the F508del-CFTR mutation: a phase 3, open-label, extension study
33. CFTR-function and ventilation inhomogeneity in individuals with cystic fibrosis
34. PROMISE: Working with the CF community to understand emerging clinical and research needs for those treated with highly effective CFTR modulator therapy
35. Projecting the impact of delayed access to elexacaftor/tezacaftor/ivacaftor for people with Cystic Fibrosis
36. Aerosolized lancovutide in adolescents (≥12 years) and adults with cystic fibrosis – a randomized trial
37. Cystic fibrosis–related diabetes onset can be predicted using biomarkers measured at birth
38. Performance Characteristics of Spirometry With Negative Bronchodilator Response and Methacholine Challenge Testing and Implications for Asthma Diagnosis
39. Integrating the multiple breath washout test into international multicentre trials
40. Changes in the parent cystic fibrosis questionnaire-revised (CFQ-R) with respiratory symptoms in preschool children with cystic fibrosis
41. Antimicrobial resistance in cystic fibrosis: A Delphi approach to defining best practices
42. The future of cystic fibrosis care: a global perspective
43. Exhaled Breath Analysis Detects the Clearance of Staphylococcus aureus from the Airways of Children with Cystic Fibrosis
44. Incidence and risk factors of paediatric cystic fibrosis-related diabetes
45. Lavage lipidomics signatures in children with cystic fibrosis and protracted bacterial bronchitis
46. Proteomic Profiling to Identify Blood Biomarkers Predictive of Response to Azithromycin in Children and Adolescents With Cystic Fibrosis
47. Inhaled hypertonic saline in preschool children with cystic fibrosis (SHIP): a multicentre, randomised, double-blind, placebo-controlled trial
48. A two-center analysis of hyperpolarized 129Xe lung MRI in stable pediatric cystic fibrosis: Potential as a biomarker for multi-site trials
49. Eradication of early P. aeruginosa infection in children
50. The CF Canada-Sick Kids Program in individual CF therapy: A resource for the advancement of personalized medicine in CF
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.